ICLR
ICON Public Limited Company
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+18/100
Last price
161.69
▼ 6.64 (3.94%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
168.33
Day high
177.67
Day low
161.26
Volume
984.01K
Market cap
$12.48B
P/E (TTM)
170.20
52W range
66.57 – 203.91
Trailing performance
Returnvs SPY
1W
-5.08%
-7.0%
1M
-1.92%
-3.1%
3M
-2.28%
-6.8%
6M
+50.89%
+32.7%
YTD
-11.27%
-25.5%
1Y
-16.61%
-33.0%
3Y
-34.34%
-116.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on ICLR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+7.64K
Net buying
Buy transactions
9
18.09K shares
Sell transactions
9
10.45K shares
Net transactions
+18
Buys less sells
Sell : buy shares
0.6 : 1
Mixed
Insider-held shares
342.56K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 11, 26 | CLERKIN NIGEL Chief Financial Officer |
SELL | 2.27K | $372.44K | Direct |
| Aug 11, 26 | GRAIS LINDA SUE M.D. Director |
SELL | 841 | $138.17K | Direct |
| Aug 11, 26 | CLIMAX JOHN PH.D. Director |
SELL | 841 | $138.17K | Direct |
| Aug 11, 26 | MURRAY CIARAN Director |
SELL | 2.68K | $439.80K | Direct |
| Aug 11, 26 | WHITAKER ANNE CLEM Director |
SELL | 841 | $138.17K | Direct |
| Aug 11, 26 | O'NEILL JULIE ANN Director |
SELL | 915 | $150.33K | Direct |
| Aug 11, 26 | MURPHY RONAN MARTIN Director |
SELL | 841 | $138.17K | Direct |
| Aug 11, 26 | MCCAGUE EUGENE PACELLI Director |
SELL | 841 | $138.17K | Direct |
| Aug 10, 26 | CLERKIN NIGEL Chief Financial Officer |
— | 4.29K | — | Direct |
| Aug 10, 26 | GRAIS LINDA SUE M.D. Director |
— | 1.73K | — | Direct |
| Aug 10, 26 | CLIMAX JOHN PH.D. Director |
— | 1.73K | — | Direct |
| Aug 10, 26 | MURRAY CIARAN Director |
— | 2.68K | — | Direct |
| Aug 10, 26 | WHITAKER ANNE CLEM Director |
— | 1.73K | — | Direct |
| Aug 10, 26 | O'NEILL JULIE ANN Director |
— | 1.73K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BALFE BARRY EDWARD |
Chief Executive Officer | 4.80K | Sale |
CLERKIN NIGEL |
Chief Financial Officer | 5.88K | Sale |
CLIMAX JOHN PH.D. |
Director | 2.09K | Sale |
GRAIS LINDA SUE M.D. |
Director | 6.16K | Sale |
MCCAGUE EUGENE PACELLI |
Director | 3.81K | Sale |
MURPHY RONAN MARTIN |
Director | 3.85K | Sale |
MURRAY CIARAN |
Director | 20.45K | Sale |
O'NEILL JULIE ANN |
Director | 3.52K | Sale |
WHITAKER ANNE CLEM |
Director | 891 | Sale |
Fundamentals
Market cap$12.48B
Enterprise value$15.07B
Revenue (TTM)$8.29B
Gross profit$1.98B
EBITDA$523.48M
Net income$27.04M
EPS (TTM)$0.95
Free cash flow$622.65M
Total cash$928.39M
Total debt$3.53B
Book value / share$121.55
Shares outstanding77.15M
Float77.10M
Short % of float3.85%
Dividend yield0.00%
Beta (5Y)1.24
Valuation & profitability ratios
Trailing P/E170.20
Forward P/E13.68
PEG ratio0.49
Price / sales—
Price / book1.33
EV / revenue1.82
EV / EBITDA28.79
Gross margin23.91%
Operating margin9.41%
Profit margin0.33%
Return on equity0.29%
Return on assets0.97%
Debt / equity37.60
Current ratio0.95
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.25B | $8.19B | $8.05B | $7.74B | +0.8% |
| Operating revenue | $8.25B | $8.19B | $8.05B | $7.74B | +0.8% |
| Cost of revenue | $6.08B | $5.82B | $5.71B | $5.53B | +4.4% |
| Gross profit | $2.18B | $2.37B | $2.35B | $2.21B | -8.2% |
| Selling, general & admin | $780.14M | $728.35M | $768.56M | $778.75M | +7.1% |
| Total operating expense | $1.16B | $1.22B | $1.35B | $1.35B | -4.4% |
| Operating income | $1.01B | $1.15B | $994.23M | $866.08M | -12.3% |
| Net interest income | -$190.38M | -$228.63M | -$331.69M | -$227.39M | +16.7% |
| Pre-tax income | $252.47M | $803.76M | $572.98M | $567.85M | -68.6% |
| Tax provision | $23.13M | $64.63M | $18.39M | $59.41M | -64.2% |
| Net income | $229.34M | $739.13M | $554.21M | $505.30M | -69.0% |
| Net income to common | $229.34M | $739.13M | $554.21M | $505.30M | -69.0% |
| Basic EPS | 2.92 | 8.96 | 6.75 | 6.21 | -67.4% |
| Diluted EPS | 2.90 | 8.90 | 6.70 | 6.13 | -67.4% |
| EBIT | $440.57M | $1.01B | $884.00M | $777.04M | -56.4% |
| EBITDA | $823.57M | $1.50B | $1.47B | $1.35B | -45.0% |
| Basic shares | 78.42M | 82.48M | 82.10M | 81.53M | -4.9% |
| Diluted shares | 78.97M | 83.03M | 82.72M | 82.54M | -4.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $647.29M | $538.78M | $378.10M | $288.77M | +20.1% |
| Cash & short-term investments | $647.29M | $538.78M | $380.06M | $290.48M | +20.1% |
| Accounts receivable | $1.47B | $1.39B | $1.76B | $1.73B | +5.9% |
| Total current assets | $3.50B | $3.28B | $3.29B | $3.23B | +6.9% |
| Property, plant & equipment | $524.67M | $530.48M | $501.52M | $504.15M | -1.1% |
| Goodwill & intangibles | $11.98B | $12.61B | $12.88B | $13.25B | -5.0% |
| Total assets | $16.27B | $16.63B | $16.86B | $17.19B | -2.2% |
| Total current liabilities | $3.20B | $2.64B | $2.73B | $2.69B | +21.3% |
| Current debt | $529.76M | $29.76M | $110.15M | $55.15M | +1,680.0% |
| Long-term debt | $2.87B | $3.40B | $3.67B | $4.60B | -15.4% |
| Total debt | $3.56B | $3.60B | $3.94B | $4.83B | -1.3% |
| Total liabilities | $7.08B | $7.19B | $7.65B | $8.69B | -1.6% |
| Retained earnings | $2.12B | $2.64B | $2.40B | $1.82B | -19.7% |
| Shareholder equity | $9.19B | $9.44B | $9.21B | $8.50B | -2.6% |
| Working capital | $305.50M | $639.68M | $556.88M | $538.47M | -52.2% |
| Net tangible assets | -$2.79B | -$3.17B | -$3.67B | -$4.75B | +12.1% |
| Shares issued | 76.57M | 80.76M | 82.50M | 81.72M | -5.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $229.34M | $739.13M | $554.21M | $505.30M | -69.0% |
| Depreciation & amortisation | $383.00M | $488.50M | $585.95M | $569.51M | -21.6% |
| Stock-based compensation | $102.04M | $45.87M | $55.67M | $70.52M | +122.5% |
| Change in working capital | -$98.10M | -$1.82M | -$54.30M | -$550.22M | -5,290.3% |
| Operating cash flow | $1.04B | $1.29B | $1.16B | $563.32M | -19.5% |
| Capital expenditure | -$174.21M | -$168.06M | -$140.69M | -$142.16M | -3.7% |
| Investing cash flow | -$187.53M | -$266.79M | -$226.65M | -$145.87M | +29.7% |
| Share buybacks | -$750.00M | -$500.00M | $0 | -$99.98M | -50.0% |
| Financing cash flow | -$771.26M | -$837.18M | -$844.04M | -$864.17M | +7.9% |
| Free cash flow | $861.99M | $1.12B | $1.02B | $421.15M | -22.9% |
| End cash position | $647.29M | $538.78M | $378.10M | $288.77M | +20.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.06B | $2.03B | $2.19B | $2.08B | $2.04B | +1.4% |
| Operating revenue | $2.06B | $2.03B | $2.19B | $2.08B | $2.04B | +1.4% |
| Cost of revenue | $1.58B | $1.56B | $1.69B | $1.54B | $1.46B | +1.8% |
| Gross profit | $479.29M | $477.93M | $500.89M | $545.46M | $583.33M | +0.3% |
| Selling, general & admin | $194.32M | $200.60M | $179.70M | $197.05M | $205.01M | -3.1% |
| Total operating expense | $285.08M | $290.93M | $270.52M | $296.08M | $302.72M | -2.0% |
| Operating income | $194.21M | $187.00M | $230.37M | $249.38M | $280.61M | +3.9% |
| Net interest income | -$45.63M | -$46.18M | -$47.99M | -$48.48M | -$48.10M | +1.2% |
| Pre-tax income | $92.20M | $127.56M | -$120.50M | -$271.39M | $182.84M | -27.7% |
| Tax provision | $19.61M | $22.81M | -$10.36M | $12.79M | -$20.67M | -14.0% |
| Net income | $72.58M | $104.75M | -$110.14M | -$284.18M | $203.52M | -30.7% |
| Net income to common | $72.58M | $104.75M | -$110.14M | -$284.18M | $203.52M | -30.7% |
| Basic EPS | 0.94 | 1.37 | 1.95 | -3.67 | 2.57 | -31.4% |
| Diluted EPS | 0.94 | 1.36 | 1.93 | -3.67 | 2.56 | -30.9% |
| EBIT | $140.98M | $175.56M | -$80.40M | -$221.15M | $232.99M | -19.7% |
| EBITDA | $231.75M | $265.89M | $10.43M | -$122.12M | $330.71M | -12.8% |
| Basic shares | 76.85M | 76.58M | 76.52M | 77.37M | 79.25M | +0.3% |
| Diluted shares | 77.37M | 77.26M | 77.31M | 77.37M | 79.55M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $928.38M | $765.16M | $647.29M | $468.89M | $390.40M | +21.3% |
| Cash & short-term investments | $928.38M | $765.16M | $647.29M | $468.89M | $390.40M | +21.3% |
| Accounts receivable | $1.46B | $1.47B | $1.47B | $1.39B | $1.37B | -0.9% |
| Total current assets | $3.75B | $3.61B | $3.50B | $3.41B | $3.31B | +3.9% |
| Property, plant & equipment | $500.29M | $508.36M | $524.67M | $525.18M | $518.33M | -1.6% |
| Goodwill & intangibles | $11.87B | $11.92B | $11.98B | $12.31B | $12.54B | -0.5% |
| Total assets | $16.40B | $16.32B | $16.27B | $16.51B | $16.60B | +0.5% |
| Total current liabilities | $3.93B | $3.17B | $3.20B | $3.22B | $2.56B | +24.1% |
| Current debt | $1.28B | $529.76M | $529.76M | $529.76M | $29.76M | +141.6% |
| Long-term debt | $2.11B | $2.87B | $2.87B | $2.88B | $3.38B | -26.4% |
| Total debt | $3.49B | $3.51B | $3.56B | $3.53B | $3.55B | -0.4% |
| Total liabilities | $7.02B | $7.02B | $7.08B | $7.17B | $7.05B | +0.0% |
| Retained earnings | $2.30B | $2.23B | $2.12B | $2.31B | $2.56B | +3.3% |
| Shareholder equity | $9.38B | $9.30B | $9.19B | $9.33B | $9.56B | +0.8% |
| Working capital | -$186.02M | $437.80M | $305.50M | $189.43M | $752.44M | -142.5% |
| Net tangible assets | -$2.49B | -$2.62B | -$2.79B | -$2.98B | -$2.98B | +5.1% |
| Shares issued | 77.15M | 76.60M | 76.57M | 76.36M | 77.77M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $72.58M | $104.75M | -$110.14M | -$203.52M | $203.52M | -30.7% |
| Depreciation & amortisation | $90.77M | $90.33M | $90.83M | -$97.72M | $97.72M | +0.5% |
| Stock-based compensation | $18.46M | $27.57M | $29.51M | -$15.25M | $15.25M | -33.1% |
| Change in working capital | $64.37M | -$30.44M | -$37.72M | $189.58M | -$189.58M | +311.5% |
| Operating cash flow | $281.27M | $167.01M | $234.16M | -$146.20M | $146.20M | +68.4% |
| Capital expenditure | -$42.42M | -$30.77M | -$59.33M | -$53.70M | -$32.28M | -37.9% |
| Investing cash flow | -$108.34M | -$39.44M | -$55.94M | $38.21M | -$38.21M | -174.7% |
| Share buybacks | $0 | $0 | $0 | $250.00M | -$250.00M | — |
| Financing cash flow | -$8.12M | -$6.36M | -$5.79M | $255.86M | -$255.86M | -27.7% |
| Free cash flow | $238.85M | $136.24M | $174.83M | -$113.92M | $113.92M | +75.3% |
| End cash position | $928.38M | $765.16M | $647.29M | $526.70M | $390.40M | +21.3% |
Options analytics
Put / call volume
0.66
Call-heavy session
Put / call open interest
0.53
Positioning, not flow
Max pain
165.00
+2.0% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
235
Contracts, this expiry
Put volume
156
Contracts, this expiry
Heaviest call OI
210.00
579 contracts
Heaviest put OI
165.00
599 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.52 | 2.56 | +1.7% |
| Mar 2026 | 2.43 | 2.50 | +3.1% |
| Dec 2025 | 3.11 | 2.52 | -18.9% |
| Sep 2025 | 3.28 | 3.31 | +1.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.65 | 15 | $2.01B | -1.5% |
| Next quarter | 2.84 | 16 | $2.02B | -4.4% |
| Current year | 10.58 | 18 | $8.14B | -1.4% |
| Next year | 11.82 | 18 | $8.43B | +3.6% |
Analyst targets & ownership
Mean target$184.41
High target$210.00
Low target$155.00
Implied upside14.05%
Analyst count17
ConsensusBUY
Strong buy / Buy1 / 9
Hold7
Sell / Strong sell0 / 1
Held by insiders0.44%
Held by institutions108.21%
Institutions holding619
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
168.00
-3.75% from price
SMA 20
168.01
-3.76% from price
SMA 50
167.22
-3.31% from price
SMA 100
158.83
+1.80% from price
SMA 200
146.28
+10.53% from price
EMA 12
166.83
-3.08% from price
EMA 26
167.23
-3.31% from price
EMA 50
165.47
-2.29% from price
RSI (14)
44.6
Neutral
MACD (12,26,9)
-0.40
Hist -0.81
ATR (14)
7.41
4.58% of price
Realised vol 30D
41.4%
Annualised
Bollinger upper
177.03
20, 2σ
Bollinger lower
158.99
20, 2σ
50 / 200 cross
Golden
167.22 vs 146.28
Trend bias
Above 200
+10.53%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.25
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
41.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-60.5%
Peak to trough
Max drawdown 5Y
-76.9%
Peak to trough
ATR 14
7.41
4.58% of price
Beta (reported)
1.24
5Y monthly, from filing
Short interest
Shares short
2.63M
Prior 2.22M
Change vs prior
+18.3%
Shorts adding
% of float
3.85%
Normal
% of shares out
3.40%
Against total outstanding
Days to cover
3.7
Liquid
Float
77.10M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 18, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 31, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 31, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jun 30, 26 | Truist Securities | UPGRADE | Hold | Buy |
| Jun 26, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jun 25, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jun 25, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Jun 25, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jun 25, 26 | RBC Capital | UPGRADE | Sector Perform | Outperform |
| Jun 25, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jun 25, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Jun 25, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateAug 13, 2008
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-09-09
Corporate Changes & Voting Matters
6-K · 2026-08-20
Corporate Changes & Voting Matters
6-K · 2026-08-18
Corporate Changes & Voting Matters
6-K · 2026-08-06
Corporate Changes & Voting Matters
6-K · 2026-07-31
Corporate Changes & Voting Matters
6-K · 2026-07-30
Corporate Changes & Voting Matters
6-K · 2026-07-29
Corporate Changes & Voting Matters
6-K · 2026-07-22
Headlines
UBS Downgrades ICON to Neutral From Buy
MT Newswires · 7d ago
ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure
Insider Monkey · 15d ago
Icon Insider Sold Shares Worth $875,875, According to a Recent SEC Filing
MT Newswires · 19d ago
Icon Insider Sold Shares Worth $569,625, According to a Recent SEC Filing
MT Newswires · 19d ago
Icon Insider Sold Shares Worth $875,875, According to a Recent SEC Filing
MT Newswires · 19d ago
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?
Zacks · 33d ago
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Zacks · 40d ago
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
Business Wire · 48d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.